Vivace Therapeutics is a venture-backed, oncology-focused drug discovery and development company based in San Mateo, California. The company aims to turn novel biology into first-in-class cancer therapeutics. Vivace's programs include small molecule initiatives targeting the YAP pathway and bi-specific programs. The firm leverages top scientific talent and management expertise from the U.S. and China to develop innovative treatments for cancer.
Vivace Therapeutics has made significant strides in the oncology field by focusing on groundbreaking science to create new cancer treatments. The company is committed to generating exceptional value for its shareholders and patients through a smart business strategy. With a strong foundation in scientific research and development, Vivace continues to impact the oncology landscape by advancing its portfolio of therapeutic programs.
